Press Release: Nucleix : Nucleix Announces Upcoming Presentation of Performance Data from Sightline Study of Lung EpiCheck at the American College of Chest Physicians (CHEST) 2023 Annual Meeting

SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that new data from the Sightline study of Lung EpiCheck® will be presented by Dr. Peter Mazzone from Cleveland Clinic in a late-breaking rapid-fire original investigations session during the American College of Chest Physicians (CHEST) 2023 Annual Meeting, October 8-11 in Honolulu. The presentation will showcase initial performance dat